These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 27243371

  • 1. Metabolic Patterns in Chronic Multiple Sclerosis Lesions and Normal-appearing White Matter: Intraindividual Comparison by Using 2D MR Spectroscopic Imaging.
    Fleischer V, Kolb R, Groppa S, Zipp F, Klose U, Gröger A.
    Radiology; 2016 Nov; 281(2):536-543. PubMed ID: 27243371
    [Abstract] [Full Text] [Related]

  • 2. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
    Chen W, Zhang Y, Mu K, Pan C, Gauthier SA, Zhu W, Wang Y.
    AJR Am J Roentgenol; 2017 Oct; 209(4):889-894. PubMed ID: 28705068
    [Abstract] [Full Text] [Related]

  • 3. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis.
    Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, Miller DH.
    Brain; 2002 Oct; 125(Pt 10):2342-52. PubMed ID: 12244090
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneity of acute multiple sclerosis lesions on sodium (23Na) MRI.
    Eisele P, Konstandin S, Griebe M, Szabo K, Wolf ME, Alonso A, Ebert A, Serwane J, Rossmanith C, Hennerici MG, Schad LR, Gass A.
    Mult Scler; 2016 Jul; 22(8):1040-7. PubMed ID: 26453681
    [Abstract] [Full Text] [Related]

  • 5. Tissue damage within normal appearing white matter in early multiple sclerosis: assessment by the ratio of T1- and T2-weighted MR image intensity.
    Beer A, Biberacher V, Schmidt P, Righart R, Buck D, Berthele A, Kirschke J, Zimmer C, Hemmer B, Mühlau M.
    J Neurol; 2016 Aug; 263(8):1495-502. PubMed ID: 27178000
    [Abstract] [Full Text] [Related]

  • 6. Abnormal blood-brain barrier water exchange in chronic multiple sclerosis lesions: A preliminary study.
    Wengler K, Ha J, Syritsyna O, Bangiyev L, Coyle PK, Duong TQ, Schweitzer ME, He X.
    Magn Reson Imaging; 2020 Jul; 70():126-133. PubMed ID: 32353529
    [Abstract] [Full Text] [Related]

  • 7. Grey:white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression.
    Moccia M, Quarantelli M, Lanzillo R, Cocozza S, Carotenuto A, Carotenuto B, Alfano B, Prinster A, Triassi M, Nardone A, Palladino R, Brunetti A, Brescia Morra V.
    Eur J Neurol; 2017 Jan; 24(1):195-204. PubMed ID: 27801535
    [Abstract] [Full Text] [Related]

  • 8. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C.
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [Abstract] [Full Text] [Related]

  • 9. Characterization of Axonal Disease in Patients with Multiple Sclerosis Using High-Gradient-Diffusion MR Imaging.
    Huang SY, Tobyne SM, Nummenmaa A, Witzel T, Wald LL, McNab JA, Klawiter EC.
    Radiology; 2016 Jul; 280(1):244-51. PubMed ID: 26859256
    [Abstract] [Full Text] [Related]

  • 10. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
    Ingrisch M, Sourbron S, Herberich S, Schneider MJ, Kümpfel T, Hohlfeld R, Reiser MF, Ertl-Wagner B.
    Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
    [Abstract] [Full Text] [Related]

  • 11. 7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions?
    Heckova E, Strasser B, Hangel GJ, Považan M, Dal-Bianco A, Rommer PS, Bednarik P, Gruber S, Leutmezer F, Lassmann H, Trattnig S, Bogner W.
    Invest Radiol; 2019 Apr; 54(4):247-254. PubMed ID: 30433892
    [Abstract] [Full Text] [Related]

  • 12. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O.
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [Abstract] [Full Text] [Related]

  • 13. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD, Daams M, Pouwels PJ, Balk LJ, Tewarie PK, Killestein J, Uitdehaag BM, Geurts JJ, Barkhof F, Vrenken H.
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [Abstract] [Full Text] [Related]

  • 14. Metabolic counterparts of sodium accumulation in multiple sclerosis: A whole brain 23Na-MRI and fast 1H-MRSI study.
    Donadieu M, Le Fur Y, Maarouf A, Gherib S, Ridley B, Pini L, Rapacchi S, Confort-Gouny S, Guye M, Schad LR, Maudsley AA, Pelletier J, Audoin B, Zaaraoui W, Ranjeva JP.
    Mult Scler; 2019 Jan; 25(1):39-47. PubMed ID: 29064346
    [Abstract] [Full Text] [Related]

  • 15. Spiral MRSI and tissue segmentation of normal-appearing white matter and white matter lesions in relapsing remitting multiple sclerosis patients☆.
    Al-Iedani O, Ribbons K, Gholizadeh N, Lechner-Scott J, Quadrelli S, Lea R, Andronesi O, Ramadan S.
    Magn Reson Imaging; 2020 Dec; 74():21-30. PubMed ID: 32898652
    [Abstract] [Full Text] [Related]

  • 16. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, De Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G.
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [Abstract] [Full Text] [Related]

  • 17. Diffusely appearing white matter in multiple sclerosis: Insights from sodium (23Na) MRI.
    Weber CE, Nagel K, Ebert A, Roßmanith C, Paschke N, Adlung A, Platten M, Schad LR, Gass A, Eisele P.
    Mult Scler Relat Disord; 2021 Apr; 49():102752. PubMed ID: 33486402
    [Abstract] [Full Text] [Related]

  • 18. Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.
    Heckova E, Dal-Bianco A, Strasser B, Hangel GJ, Lipka A, Motyka S, Hingerl L, Rommer PS, Berger T, Hnilicová P, Kantorová E, Leutmezer F, Kurča E, Gruber S, Trattnig S, Bogner W.
    Radiology; 2022 Apr; 303(1):141-150. PubMed ID: 34981978
    [Abstract] [Full Text] [Related]

  • 19. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J, Pelletier D, Nelson SJ.
    Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
    Sucksdorff M, Rissanen E, Tuisku J, Nuutinen S, Paavilainen T, Rokka J, Rinne J, Airas L.
    J Nucl Med; 2017 Oct; 58(10):1646-1651. PubMed ID: 28336784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.